Fruquintinib-induced renal-limited thrombotic microangiopathy: a case report
Abstract Background Fruquintinib is a highly selective inhibitor of vascular endothelial growth factor receptor (VEGFR). Currently, there are no reported cases of fruquintinib causing kidney-restrictive thrombotic microangiopathy (TMA) in the available Chinese and foreign literature. Case presentati...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
BMC
2024-05-01
|
Serier: | BMC Nephrology |
Fag: | |
Online adgang: | https://doi.org/10.1186/s12882-024-03598-8 |